Peter-Paul Zwetsloot

Peter-Paul Zwetsloot is a Researcher in the Department of Cardiology at Erasmus MC, a leading academic medical center in the Netherlands. His work is highly specialized in hypertrophic cardiomyopathy and related cardiovascular conditions, with a strong emphasis on genetic and phenotypic expression.

The research interests of Dr. Zwetsloot span several critical areas in modern cardiology, including genotype-negative hypertrophic cardiomyopathy, cardiovascular risk stratification, quality of life assessments in cardiac patients, and the innovative use of artificial intelligence in ECG interpretation for early detection of systolic dysfunction in muscular dystrophies. His work bridges clinical cardiology with data science and patient-centered outcomes.

His recent publications indicate a strong trend toward integrating clinical data with advanced analytics and focusing on both genetic and non-genetic factors in disease expression. He frequently collaborates on studies involving large patient cohorts and multidisciplinary teams, contributing to high-impact journals such as the International Journal of Cardiology and Open Heart.

While no scientific awards are mentioned in the available text, his research has been cited in Scopus and has attracted attention in academic and public spheres, including mentions on X (formerly Twitter), Mendeley, and news outlets.

Dr. Zwetsloot participates in significant collaborative research projects, particularly within the cardiology division at Erasmus MC. He is part of a team conducting long-term follow-up studies on genotype-positive individuals and exploring psychometric tools for evaluating patient well-being. His involvement in AI-driven diagnostics suggests engagement with emerging technologies in cardiovascular screening.